Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Eric Scott Rosenberg, M.D.

TitleAssociate Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
Infectious Disease, GRJ 529
55 Fruit St
Boston MA 02114
Phone617/726-3812
Fax617/726-7416

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Buzon MJ, Yang Y, Ouyang Z, Sun H, Seiss K, Rogich J, Le Gall S, Pereyra F, Rosenberg ES, Yu XG, Lichterfeld M. Susceptibility to CD8 T-Cell-Mediated Killing Influences the Reservoir of Latently HIV-1-Infected CD4 T Cells. J Acquir Immune Defic Syndr. 2014 Jan 1; 65(1):1-9.
    View in: PubMed
  2. Vaidya SA, Streeck H, Beckwith N, Ghebremichael M, Pereyra F, Kwon DS, Addo MM, Rychert J, Routy JP, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Carrington M, Walker BD, Allen TM, Rosenberg ES, Altfeld M. Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology. 2013; 10(1):139.
    View in: PubMed
  3. Simmons RP, Scully EP, Groden EE, Arnold KB, Chang JJ, Lane K, Lifson J, Rosenberg E, Lauffenburger DA, Altfeld M. HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways. AIDS. 2013 Oct 23; 27(16):2505-17.
    View in: PubMed
  4. Lichterfeld M, Rosenberg ES. Acute HIV-1 Infection: A Call to Action. Ann Intern Med. 2013 Sep 17; 159(6):425-7.
    View in: PubMed
  5. Branda JA, Rosenberg ES. Borrelia miyamotoi: A Lesson in Disease Discovery. Ann Intern Med. 2013 Jul 2; 159(1):61-2.
    View in: PubMed
  6. Rychert J, Jones L, McGrath G, Bazner S, Rosenberg ES. A monoclonal antibody against lymphocyte function-associated antigen-1 decreases HIV-1 replication by inducing the secretion of an antiviral soluble factor. Virol J. 2013; 10:120.
    View in: PubMed
  7. Shenoy ES, Kim J, Rosenberg ES, Cotter JA, Lee H, Walensky RP, Hooper DC. Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus: A Randomized Controlled Trial Comparing Passive and Active Screening With Culture and Polymerase Chain Reaction. Clin Infect Dis. 2013 Jul; 57(2):176-84.
    View in: PubMed
  8. Li C, Toth I, Schulze Zur Wiesch J, Pereyra F, Rychert J, Rosenberg ES, van Lunzen J, Lichterfeld M, Yu XG. Functional Characterization of HLA-G(+) Regulatory T Cells in HIV-1 Infection. PLoS Pathog. 2013 Jan; 9(1):e1003140.
    View in: PubMed
  9. Thobakgale CF, Fadda L, Lane K, Toth I, Pereyra F, Bazner S, Ndung'u T, Walker BD, Rosenberg ES, Alter G, Carrington M, Allen TM, Altfeld M. Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection. J Virol. 2012 Jun; 86(12):6986-93.
    View in: PubMed
  10. Brockman MA, Chopera DR, Olvera A, Brumme CJ, Sela J, Markle TJ, Martin E, Carlson JM, Le AQ, McGovern R, Cheung PK, Kelleher AD, Jessen H, Markowitz M, Rosenberg E, Frahm N, Sanchez J, Mallal S, John M, Harrigan PR, Heckerman D, Brander C, Walker BD, Brumme ZL. Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. J Virol. 2012 Jun; 86(12):6913-23.
    View in: PubMed
  11. Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi PA, Miller A, Mokhtarani M, Iklé D, Murphy S, Kopetskie H, Ding L, Rosenberg E, Spencer C, Zamvil SS. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology. 2012 Apr 10; 78(15):1171-8.
    View in: PubMed
  12. Yang Y, Al-Mozaini M, Buzon MJ, Beamon J, Ferrando-Martinez S, Ruiz-Mateos E, Rosenberg ES, Pereyra F, Yu XG, Lichterfeld M. CD4 T-cell regeneration in HIV-1 elite controllers. AIDS. 2012 Mar 27; 26(6):701-6.
    View in: PubMed
  13. Chang JJ, Lacas A, Lindsay RJ, Doyle EH, Axten KL, Pereyra F, Rosenberg ES, Walker BD, Allen TM, Altfeld M. Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection. AIDS. 2012 Mar 13; 26(5):533-41.
    View in: PubMed
  14. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, Berlin AM, Malboeuf CM, Ryan EM, Gnerre S, Zody MC, Erlich RL, Green LM, Berical A, Wang Y, Casali M, Streeck H, Bloom AK, Dudek T, Tully D, Newman R, Axten KL, Gladden AD, Battis L, Kemper M, Zeng Q, Shea TP, Gujja S, Zedlack C, Gasser O, Brander C, Hess C, Günthard HF, Brumme ZL, Brumme CJ, Bazner S, Rychert J, Tinsley JP, Mayer KH, Rosenberg E, Pereyra F, Levin JZ, Young SK, Jessen H, Altfeld M, Birren BW, Walker BD, Allen TM. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 2012; 8(3):e1002529.
    View in: PubMed
  15. Lichterfeld M, Cung T, Seiss K, Rosenberg ES, Pereyra F, Yu XG. Shelterin dysfunction and p16(INK4a)-mediated growth inhibition in HIV-1-specific CD8 T cells. J Virol. 2012 May; 86(10):5533-40.
    View in: PubMed
  16. Rosenberg EI, Bass PF, Davidson RA. Arriving at correct conclusions: the importance of association, causality, and clinical significance. South Med J. 2012 Mar; 105(3):161-6.
    View in: PubMed
  17. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med. 2012 Feb 29; 4(123):123ra25.
    View in: PubMed
  18. Lichterfeld M, Rosenberg ES. Antiretroviral combination therapy markedly reduces risk of heterosexual HIV-1 transmission. Evid Based Med. 2012 Jun; 17(3):95-6.
    View in: PubMed
  19. Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011 Oct 15; 204(8):1227-36.
    View in: PubMed
  20. Huang J, Yang Y, Al-Mozaini M, Burke PS, Beamon J, Carrington MF, Seiss K, Rychert J, Rosenberg ES, Lichterfeld M, Yu XG. Dendritic cell dysfunction during primary HIV-1 infection. J Infect Dis. 2011 Nov 15; 204(10):1557-62.
    View in: PubMed
  21. Chen YB, Driscoll JP, McAfee SL, Spitzer TR, Rosenberg ES, Sanders R, Moss RB, Fang F, Marty FM. Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation. Clin Infect Dis. 2011 Oct; 53(7):e77-80.
    View in: PubMed
  22. Tang H, Robinson JE, Gnanakaran S, Li M, Rosenberg ES, Perez LG, Haynes BF, Liao HX, Labranche CC, Korber BT, Montefiori DC. epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals. J Virol. 2011 Sep; 85(18):9286-99.
    View in: PubMed
  23. Buzon MJ, Seiss K, Weiss R, Brass AL, Rosenberg ES, Pereyra F, Yu XG, Lichterfeld M. Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers. J Virol. 2011 Sep; 85(18):9646-50.
    View in: PubMed
  24. Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis. 2011 Jul 1; 204(1):154-63.
    View in: PubMed
  25. Lentz MR, Kim WK, Kim H, Soulas C, Lee V, Venna N, Halpern EF, Rosenberg ES, Williams K, González RG. Alterations in brain metabolism during the first year of HIV infection. J Neurovirol. 2011 Jun; 17(3):220-9.
    View in: PubMed
  26. Chen H, Li C, Huang J, Cung T, Seiss K, Beamon J, Carrington MF, Porter LC, Burke PS, Yang Y, Ryan BJ, Liu R, Weiss RH, Pereyra F, Cress WD, Brass AL, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest. 2011 Apr; 121(4):1549-60.
    View in: PubMed
  27. Kim JY, Rosenberg ES. The sum of the parts is greater than the whole: reducing blood culture contamination. Ann Intern Med. 2011 Feb 1; 154(3):202-3.
    View in: PubMed
  28. Picard MH, Rosenfield K, Digumarthy S, Smith RN. Case records of the Massachusetts General Hospital. Case 40-2010. A 68-year-old woman with chest pain during an airplane flight. N Engl J Med. 2010 Dec 30; 363(27):2652-61.
    View in: PubMed
  29. Friedman LS, Gee MS, Misdraji J. Case records of the Massachusetts General Hospital. Case 39-2010. A 19-year-old woman with nausea, jaundice, and pruritus. N Engl J Med. 2010 Dec 23; 363(26):2548-57.
    View in: PubMed
  30. Vigneault F, Woods M, Buzon MJ, Li C, Pereyra F, Crosby SD, Rychert J, Church G, Martinez-Picado J, Rosenberg ES, Telenti A, Yu XG, Lichterfeld M. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol. 2011 Mar; 85(6):3015-9.
    View in: PubMed
  31. Cabot RC, Harris NL, Shepard JA, Rosenberg ES, Cort AM, Ebeling SH, Peters CC, Misra M, Parangi S, Ross DS, Shailam R, Sadow PM. Case records of the Massachusetts General Hospital: Case 38-2010: a 13-year-old girl with an enlarging neck mass. N Engl J Med. 2010 Dec 16; 363(25):2445-54.
    View in: PubMed
  32. Binder WD, Traum AZ, Makar RS, Colvin RB. Case records of the Massachusetts General Hospital. Case 37-2010. A 16-year-old girl with confusion, anemia, and thrombocytopenia. N Engl J Med. 2010 Dec 9; 363(24):2352-61.
    View in: PubMed
  33. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, Olender SA, Ostrowski M, Owen WF, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7.
    View in: PubMed
  34. Chevalier MF, Jülg B, Pyo A, Flanders M, Ranasinghe S, Soghoian DZ, Kwon DS, Rychert J, Lian J, Muller MI, Cutler S, McAndrew E, Jessen H, Pereyra F, Rosenberg ES, Altfeld M, Walker BD, Streeck H. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol. 2011 Jan; 85(2):733-41.
    View in: PubMed
  35. Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis. 2010 Oct 15; 202 Suppl 2:S278-88.
    View in: PubMed
  36. Hunt DP, Thabet A, Rosenberg ES. Case records of the Massachusetts General Hospital. Case 29-2010. A 29-year-old woman with fever and abdominal pain. N Engl J Med. 2010 Sep 23; 363(13):1266-74.
    View in: PubMed
  37. Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, Kadie CM, Carlson JM, Markle TJ, Streeck H, Kelleher AD, Markowitz M, Jessen H, Rosenberg E, Altfeld M, Harrigan PR, Heckerman D, Walker BD, Allen TM. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol. 2010 Nov; 84(22):11937-49.
    View in: PubMed
  38. Rychert J, Strick D, Bazner S, Robinson J, Rosenberg E. Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. AIDS Res Hum Retroviruses. 2010 Oct; 26(10):1139-45.
    View in: PubMed
  39. Williams K, Seiss K, Beamon J, Pereyra F, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. Epigenetic regulation of telomerase expression in HIV-1-specific CD8+ T cells. AIDS. 2010 Jul 31; 24(12):1964-6.
    View in: PubMed
  40. Miura T, Brumme ZL, Brockman MA, Rosato P, Sela J, Brumme CJ, Pereyra F, Kaufmann DE, Trocha A, Block BL, Daar ES, Connick E, Jessen H, Kelleher AD, Rosenberg E, Markowitz M, Schafer K, Vaida F, Iwamoto A, Little S, Walker BD. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol. 2010 Aug; 84(15):7581-91.
    View in: PubMed
  41. Rosenberg ES, Graham BS, Chan ES, Bosch RJ, Stocker V, Maenza J, Markowitz M, Little S, Sax PE, Collier AC, Nabel G, Saindon S, Flynn T, Kuritzkes D, Barouch DH. Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection. PLoS One. 2010; 5(5):e10555.
    View in: PubMed
  42. Davidson RA, Rosenberg E. ACP Journal Club. Review: Statins reduce mortality and cardiovascular events in adults at risk for cardiovascular disease. Ann Intern Med. 2009 Oct 20; 151(8):JC4-14.
    View in: PubMed
  43. Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, Addo MM, Brumme C, Routy JP, Little S, Jessen HK, Kelleher AD, Hecht FM, Sekaly RP, Rosenberg ES, Walker BD, Carrington M, Altfeld M. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol. 2009 Aug; 83(15):7641-8.
    View in: PubMed
  44. Lentz MR, Kim WK, Lee V, Bazner S, Halpern EF, Venna N, Williams K, Rosenberg ES, González RG. Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology. 2009 Apr 28; 72(17):1465-72.
    View in: PubMed
  45. Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg ES, Miller JS, Carrington M, Altfeld M. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol. 2009 Jul; 83(13):6798-805.
    View in: PubMed
  46. Bell SK, Rosenberg ES. Case records of the Massachusetts General Hospital. Case 11-2009. A 47-year-old man with fever, headache, rash, and vomiting. N Engl J Med. 2009 Apr 9; 360(15):1540-8.
    View in: PubMed
  47. Lubong Sabado R, Kavanagh DG, Kaufmann DE, Fru K, Babcock E, Rosenberg E, Walker B, Lifson J, Bhardwaj N, Larsson M. In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection. PLoS One. 2009; 4(1):e4256.
    View in: PubMed
  48. Schneidewind A, Brumme ZL, Brumme CJ, Power KA, Reyor LL, O'Sullivan K, Gladden A, Hempel U, Kuntzen T, Wang YE, Oniangue-Ndza C, Jessen H, Markowitz M, Rosenberg ES, Sékaly RP, Kelleher AD, Walker BD, Allen TM. Transmission and long-term stability of compensated CD8 escape mutations. J Virol. 2009 Apr; 83(8):3993-7.
    View in: PubMed
  49. Banks HT, Davidian M, Hu S, Kepler GM, Rosenberg ES. Modelling HIV immune response and validation with clinical data. J Biol Dyn. 2008 Oct; 2(4):357-85.
    View in: PubMed
  50. Lichterfeld M, Mou D, Cung TD, Williams KL, Waring MT, Huang J, Pereyra F, Trocha A, Freeman GJ, Rosenberg ES, Walker BD, Yu XG. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood. 2008 Nov 1; 112(9):3679-87.
    View in: PubMed
  51. Streeck H, Li B, Poon AF, Schneidewind A, Gladden AD, Power KA, Daskalakis D, Bazner S, Zuniga R, Brander C, Rosenberg ES, Frost SD, Altfeld M, Allen TM. Immune-driven recombination and loss of control after HIV superinfection. J Exp Med. 2008 Aug 4; 205(8):1789-96.
    View in: PubMed
  52. Brumme ZL, Brumme CJ, Carlson J, Streeck H, John M, Eichbaum Q, Block BL, Baker B, Kadie C, Markowitz M, Jessen H, Kelleher AD, Rosenberg E, Kaldor J, Yuki Y, Carrington M, Allen TM, Mallal S, Altfeld M, Heckerman D, Walker BD. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol. 2008 Sep; 82(18):9216-27.
    View in: PubMed
  53. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, Brumme CJ, Rosenberg ES, Alter G, Allen TM, Walker BD, Altfeld M. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008 May 6; 5(5):e100.
    View in: PubMed
  54. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, Baker B, Trocha A, Rosenberg R, Mackey E, Ueda P, Lu Z, Cohen D, Wrin T, Petropoulos CJ, Rosenberg ES, Walker BD. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008 Feb 15; 197(4):563-71.
    View in: PubMed
  55. Lichterfeld M, Kavanagh DG, Williams KL, Moza B, Mui SK, Miura T, Sivamurthy R, Allgaier R, Pereyra F, Trocha A, Feeney M, Gandhi RT, Rosenberg ES, Altfeld M, Allen TM, Allen R, Walker BD, Sundberg EJ, Yu XG. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med. 2007 Nov 26; 204(12):2813-24.
    View in: PubMed
  56. Babyatsky MW, Keroack MD, Blake MA, Rosenberg ES, Mino-Kenudson M. Case records of the Massachusetts General Hospital. Case 35-2007. A 30-year-old man with inflammatory bowel disease and recent onset of fever and bloody diarrhea. N Engl J Med. 2007 Nov 15; 357(20):2068-76.
    View in: PubMed
  57. Rychert J, Saindon S, Placek S, Daskalakis D, Rosenberg E. Sequence variation occurs in CD4 epitopes during early HIV infection. J Acquir Immune Defic Syndr. 2007 Nov 1; 46(3):261-7.
    View in: PubMed
  58. Kiepiela P, Smith AN, Rosenberg E. Retraction notice to "Laboratory markers associated with progression of HIV infection [Best Practice & Research Clinical Obstetrics & Gynaecology 19 (2005) 243-254]". Best Pract Res Clin Obstet Gynaecol. 2007 Oct; 21(5):883.
    View in: PubMed
  59. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, Miura T, Palmer S, Brockman M, Rathod A, Piechocka-Trocha A, Baker B, Zhu B, Le Gall S, Waring MT, Ahern R, Moss K, Kelleher AD, Coffin JM, Freeman GJ, Rosenberg ES, Walker BD. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol. 2007 Nov; 8(11):1246-54.
    View in: PubMed
  60. Streeck H, Lichterfeld M, Alter G, Meier A, Teigen N, Yassine-Diab B, Sidhu HK, Little S, Kelleher A, Routy JP, Rosenberg ES, Sekaly RP, Walker BD, Altfeld M. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol. 2007 Jul; 81(14):7725-31.
    View in: PubMed
  61. Staton LJ, Panda M, Chen I, Genao I, Kurz J, Pasanen M, Mechaber AJ, Menon M, O'Rorke J, Wood J, Rosenberg E, Faeslis C, Carey T, Calleson D, Cykert S. When race matters: disagreement in pain perception between patients and their physicians in primary care. J Natl Med Assoc. 2007 May; 99(5):532-8.
    View in: PubMed
  62. Alter G, Teigen N, Ahern R, Streeck H, Meier A, Rosenberg ES, Altfeld M. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis. 2007 May 15; 195(10):1452-60.
    View in: PubMed
  63. Addo MM, Draenert R, Rathod A, Verrill CL, Davis BT, Gandhi RT, Robbins GK, Basgoz NO, Stone DR, Cohen DE, Johnston MN, Flynn T, Wurcel AG, Rosenberg ES, Altfeld M, Walker BD. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS One. 2007; 2(3):e321.
    View in: PubMed
  64. Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, Allgaier RL, Waring MT, Koibuchi T, Johnston MN, Cohen D, Allen TM, Rosenberg ES, Walker BD, Altfeld M. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol. 2007 Apr; 81(8):4199-214.
    View in: PubMed
  65. Rosenberg ES, Davidian M, Banks HT. Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection. Drug Alcohol Depend. 2007 May; 88 Suppl 2:S41-51.
    View in: PubMed
  66. Adams BM, Banks HT, Davidian M, Rosenberg ES. Estimation and prediction with HIV-treatment interruption data. Bull Math Biol. 2007 Feb; 69(2):563-84.
    View in: PubMed
  67. Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F, Labute MX, Pfafferott K, Leslie A, Crawford H, Allgaier R, Hildebrand W, Kaslow R, Brander C, Allen TM, Rosenberg ES, Kiepiela P, Vajpayee M, Goepfert PA, Altfeld M, Goulder PJ, Walker BD. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol. 2007 Feb; 81(4):1619-31.
    View in: PubMed
  68. Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kelleher AD, Routy JP, Campbell TB, Rosenberg ES, Segal MR, Weidler J, Grant RM. Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity. AIDS. 2006 Oct 24; 20(16):2123-5.
    View in: PubMed
  69. Zaunders JJ, Ip S, Munier ML, Kaufmann DE, Suzuki K, Brereton C, Sasson SC, Seddiki N, Koelsch K, Landay A, Grey P, Finlayson R, Kaldor J, Rosenberg ES, Walker BD, Fazekas de St Groth B, Cooper DA, Kelleher AD. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol. 2006 Oct; 80(20):10162-72.
    View in: PubMed
  70. Altfeld M, Kalife ET, Qi Y, Streeck H, Lichterfeld M, Johnston MN, Burgett N, Swartz ME, Yang A, Alter G, Yu XG, Meier A, Rockstroh JK, Allen TM, Jessen H, Rosenberg ES, Carrington M, Walker BD. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med. 2006 Oct; 3(10):e403.
    View in: PubMed
  71. Lichterfeld M, Williams KL, Mui SK, Shah SS, Mothe BR, Sette A, Kim A, Johnston MN, Burgett N, Frahm N, Cohen D, Brander C, Rosenberg ES, Walker BD, Altfeld M, Yu XG. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. Int Immunol. 2006 Jul; 18(7):1179-88.
    View in: PubMed
  72. Kassutto S, Maghsoudi K, Johnston MN, Robbins GK, Burgett NC, Sax PE, Cohen D, Pae E, Davis B, Zachary K, Basgoz N, D'agata EM, DeGruttola V, Walker BD, Rosenberg ES. Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection. Clin Infect Dis. 2006 Apr 1; 42(7):1024-31.
    View in: PubMed
  73. Branda JA, Lin TY, Rosenberg ES, Halpern EF, Ferraro MJ. A rational approach to the stool ova and parasite examination. Clin Infect Dis. 2006 Apr 1; 42(7):972-8.
    View in: PubMed
  74. Daskalakis D, Rosenberg ES. Impairment of HIV-specific immune effector cell function. Cell Death During HIV Infection. 2006; 185.
  75. Evian CI, Al-Momani A, Rosenberg ES, Sanavi F. Therapeutic management for immediate implant placement in sites with periapical deficiencies where coronal bone is present: technique and case report. Int J Oral Maxillofax Implants. 2006; 21(3):476-80.
  76. Branda JA, Lin TYD, Rosenberg ES, Halpern EF, Ferraro MJ. A rationale approach to the stool ova and parasites examination. Clinical Infectious Diseases. 2006; 42(7):972-8.
  77. Meyer-Olson D, Brady KW, Bartman MT, O'Sullivan KM, Simons BC, Conrad JA, Duncan CB, Lorey S, Siddique A, Draenert R, Addo M, Altfeld M, Rosenberg E, Allen TM, Walker BD, Kalams SA. Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood. 2006 Mar 15; 107(6):2373-83.
    View in: PubMed
  78. Seth N, Kaufmann D, Lahey T, Rosenberg ES, Wucherpfennig KW. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol. 2005 Nov 15; 175(10):6948-58.
    View in: PubMed
  79. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, O'sullivan KM, Desouza I, Feeney ME, Eldridge RL, Maier EL, Kaufmann DE, Lahaie MP, Reyor L, Tanzi G, Johnston MN, Brander C, Draenert R, Rockstroh JK, Jessen H, Rosenberg ES, Mallal SA, Walker BD. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol. 2005 Nov; 79(21):13239-49.
    View in: PubMed
  80. Kavanagh DG, Kaufmann DE, Sunderji S, Frahm N, Le Gall S, Boczkowski D, Rosenberg ES, Stone DR, Johnston MN, Wagner BS, Zaman MT, Brander C, Gilboa E, Walker BD, Bhardwaj N. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood. 2006 Mar 1; 107(5):1963-9.
    View in: PubMed
  81. Allen TM, Yu XG, Kalife ET, Reyor LL, Lichterfeld M, John M, Cheng M, Allgaier RL, Mui S, Frahm N, Alter G, Brown NV, Johnston MN, Rosenberg ES, Mallal SA, Brander C, Walker BD, Altfeld M. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol. 2005 Oct; 79(20):12952-60.
    View in: PubMed
  82. Frahm N, Adams S, Kiepiela P, Linde CH, Hewitt HS, Lichterfeld M, Sango K, Brown NV, Pae E, Wurcel AG, Altfeld M, Feeney ME, Allen TM, Roach T, St John MA, Daar ES, Rosenberg E, Korber B, Marincola F, Walker BD, Goulder PJ, Brander C. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol. 2005 Aug; 79(16):10218-25.
    View in: PubMed
  83. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, Waring MT, Streeck H, Johnston MN, Staller KD, Zaman MT, Yu XG, Lichterfeld M, Basgoz N, Rosenberg ES, Altfeld M. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood. 2005 Nov 15; 106(10):3366-9.
    View in: PubMed
  84. Chen I, Kurz J, Pasanen M, Faselis C, Panda M, Staton LJ, O'Rorke J, Menon M, Genao I, Wood J, Mechaber AJ, Rosenberg E, Carey T, Calleson D, Cykert S. Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med. 2005 Jul; 20(7):593-8.
    View in: PubMed
  85. Zaunders JJ, Munier ML, Kaufmann DE, Ip S, Grey P, Smith D, Ramacciotti T, Quan D, Finlayson R, Kaldor J, Rosenberg ES, Walker BD, Cooper DA, Kelleher AD. Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection. Blood. 2005 Sep 1; 106(5):1660-7.
    View in: PubMed
  86. Kassutto S, Rosenberg ES. Editorial comment: treatment of acute HIV infection--uncertainties about best practice. AIDS Read. 2005 May; 15(5):250-1.
    View in: PubMed
  87. Xiang SH, Farzan M, Si Z, Madani N, Wang L, Rosenberg E, Robinson J, Sodroski J. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J Virol. 2005 May; 79(10):6068-77.
    View in: PubMed
  88. Altfeld M, Allen TM, Kalife ET, Frahm N, Addo MM, Mothe BR, Rathod A, Reyor LL, Harlow J, Yu XG, Perkins B, Robinson LK, Sidney J, Alter G, Lichterfeld M, Sette A, Rosenberg ES, Goulder PJ, Brander C, Walker BD. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design. J Virol. 2005 Apr; 79(8):5000-5.
    View in: PubMed
  89. Kassutto S, Johnston MN, Rosenberg ES. Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Clin Infect Dis. 2005 Mar 15; 40(6):868-73.
    View in: PubMed
  90. Kiepiela P, Smith AN, Rosenberg E. Laboratory markers associated with progression of HIV infection. Best Pract Res Clin Obstet Gynaecol. 2005 Apr; 19(2):243-54.
    View in: PubMed
  91. Seth N, Kaufmann D, Lahey T, Rosenberg ES, Wucherpfennig KW. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. Journal of Immunology. 2005; 175(10):6948-58.
  92. Robinson JE, Elliott DH, Martin EA, Micken K, Rosenberg ES. High frequencies of antibody responses to CD4 induced epitopes in HIV infected patients started on HAART during acute infection. Hum Antibodies. 2005; 14(3-4):115-21.
    View in: PubMed
  93. Kassutto S, Rosenberg ES. Editorial comment: Treatment of acute HIV infection-uncertainties about best practice. AIDS Reader. 2005; 15:249-51.
  94. Kassutto S, Johnston MN, Rosenberg ES. Incomplete HIV-1 antibody evolution and sero-reversion in acutely infected individuals treated with early antiretroviral therapy. Clinical Infectious Diseases. 2005; 40(6):868-73.
  95. Zaunders JJ, Munier ML, Kaufmann DE, Ip S, Grey P, Smith D, Ramacciotti T, Quan D, Finlayson R, Kaldor J, Rosenberg ES, Walker BD, Cooper DA, Kelleer AD. Early proliferation of CCR5+CD38+++antigen-specific CD4+Th 1 effector cells during primary HIV-1 infection. Blood. 2005; 106:1660-1670.
  96. Adams BM, Banks HT, Davidian M, Kwon HD, Tran HT, Wynne SN, Rosenberg ES. HIV dynamics: Modeling, data analysis, and optimal treatment protocols. Journal of Computational and Applied Mathematics. 2005; 184:10-49.
  97. Kaufmann DE, Lichterfeld M, Altfeld M, Addo MM, Johnston MN, Lee PK, Wagner BS, Kalife ET, Strick D, Rosenberg ES, Walker BD. Limited durability of viral control following treated acute HIV infection. PLoS Med. 2004 Nov; 1(2):e36.
    View in: PubMed
  98. Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, Johnston MN, Cohen D, Robbins GK, Pae E, Alter G, Wurcel A, Stone D, Rosenberg ES, Walker BD, Altfeld M. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med. 2004 Sep 20; 200(6):701-12.
    View in: PubMed
  99. Norris PJ, Moffett HF, Yang OO, Kaufmann DE, Clark MJ, Addo MM, Rosenberg ES. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. J Virol. 2004 Aug; 78(16):8844-51.
    View in: PubMed
  100. Lichterfeld M, Yu XG, Cohen D, Addo MM, Malenfant J, Perkins B, Pae E, Johnston MN, Strick D, Allen TM, Rosenberg ES, Korber B, Walker BD, Altfeld M. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS. 2004 Jul 2; 18(10):1383-92.
    View in: PubMed
  101. Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, Le Gall S, John M, Mothe BR, Lee PK, Kalife ET, Cohen DE, Freedberg KA, Strick DA, Johnston MN, Sette A, Rosenberg ES, Mallal SA, Goulder PJ, Brander C, Walker BD. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol. 2004 Jul; 78(13):7069-78.
    View in: PubMed
  102. Rodriguez WR, Addo MM, Rathod A, Fitzpatrick CA, Yu XG, Perkins B, Rosenberg ES, Altfeld M, Walker BD. CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects. J Transl Med. 2004 May 21; 2(1):15.
    View in: PubMed
  103. Kaufmann DE, Bailey PM, Sidney J, Wagner B, Norris PJ, Johnston MN, Cosimi LA, Addo MM, Lichterfeld M, Altfeld M, Frahm N, Brander C, Sette A, Walker BD, Rosenberg ES. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004 May; 78(9):4463-77.
    View in: PubMed
  104. Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis. 2004 May 15; 38(10):1447-53.
    View in: PubMed
  105. Lichterfeld M, Yu XG, Waring MT, Mui SK, Johnston MN, Cohen D, Addo MM, Zaunders J, Alter G, Pae E, Strick D, Allen TM, Rosenberg ES, Walker BD, Altfeld M. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood. 2004 Jul 15; 104(2):487-94.
    View in: PubMed
  106. Smith DE, Walker BD, Cooper DA, Rosenberg ES, Kaldor JM. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS. 2004 Mar 26; 18(5):709-18.
    View in: PubMed
  107. Hess C, Altfeld M, Thomas SY, Addo MM, Rosenberg ES, Allen TM, Draenert R, Eldrige RL, van Lunzen J, Stellbrink HJ, Walker BD, Luster AD. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet. 2004 Mar 13; 363(9412):863-6.
    View in: PubMed
  108. Norris PJ, Moffett HF, Brander C, Allen TM, O'Sullivan KM, Cosimi LA, Kaufmann DE, Walker BD, Rosenberg ES. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells. AIDS Res Hum Retroviruses. 2004 Mar; 20(3):315-25.
    View in: PubMed
  109. Quayle AJ, Fidel P, Rosenberg ES. Sex, alloimmunisation, and susceptibility to HIV infection. Lancet. 2004 Feb 14; 363(9408):503-4.
    View in: PubMed
  110. Ali T, Scott N, Kallas W, Halliwell ME, Savino C, Rosenberg E, Ferraro M, Hohmann E. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). Clin Infect Dis. 2004 Mar 1; 38(5):760-2.
    View in: PubMed
  111. Chien PC, Chen D, Chen PD, Tuen M, Cohen S, Migueles SA, Connors M, Rosenberg E, Malhotra U, Gonzalez C, Hioe CE. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation. J Infect Dis. 2004 Mar 1; 189(5):852-61.
    View in: PubMed
  112. Lichterfeld M, Yu XG, Waring MT, Mui SK, Johnston M, Cohen D, Addo MM, Zaunders J, Alter G, Pae E, Strick D, Allen TM, Rosenberg ES, Walker BD, Altfeld M. HIV-1 specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-(gamma) and tumor-negrosis factor-(alpha). Blood. 2004; 104:487-97.
  113. Norris PJ, Moffett HF, Yang OO, Kaufmann DE, Addo MM, Rosenberg ES. Beyond Help: Direct effector functions of HIV-1-specific CD4+T cells. Journal of Virology. 2004; 78:8844-51.
  114. Chien PC, Chen D, Chen P, Tuen M, Cohen S, Migueles SA, Connors M, Rosenberg ES, Malhotra U, Gonzalez C, Hioel CE. Human immunodeficiency virus Type 1-infected patients with envelope-specific lymphoproliferation and long-term nonprogressors lack antibodies suppressing gp120 antigen presentation. Journal of Infectious Diseases. 2004; 189:852-861.
  115. Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, Le Gall S, John M, Mothe BR, Lee PK, Kalife ET, Cohen DE, Freedberg KA, Strick DA, Johnston MN, Sette A, Rosenberg ES, Mallal SA, Goulder PJR, Brander C, Walker BD. Selection, transmission and reversion f an antigen processing CTL escape mutation in HIV-1 infection. Journal of Virology. 2004; 78:7069-78.
  116. Kassutto S, Rosenberg ES. Rapid HIV-1 testing. Point of Care. 2004; 3:123-129.
  117. Ali T, Scott N, Kallas W, Halliwell ME, Savino C, Rosenberg ES, Ferraro MJ, Hohmann E. Detection of influenza antigen using antibody-based tests after administration of live intranasal influenza vaccine (FluMist™). Clinical Infectious Diseases. 2004; 38:760-62.
  118. Kassutto S, Rosenberg ES. Primary HIV-1 infection. Clinical Infectious Diseases. 2004; 38:1447-53.
  119. Rodriguez WR, Addo MM, Rathod A, Fitzpatrick CA, Yu XG, Perkins BA, Rosenberg ES, Altfeld M, Walker BD. CD8+T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects. Journal of Translational Medicine. 2004; 2:15.
  120. Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, Johnston M, Cohen D, Robbins, GK, Pae E, Alter G, Wurcel A, Stone D, Rosenberg ES, Walker BD, ltfeld M, . Loss of HIV-1-specific CD8+T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1 specific CD4+T cells. Journal of Experimental Medicine. 2004; 200:701-12.
  121. Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M, Yu XG, Draenert R, Johnston MN, Strick D, Allen TM, Feeney ME, Kahn JO, Sekaly RP, Levy JA, Rockstroh JK, Goulder PJ, Walker BD. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS. 2003 Dec 5; 17(18):2581-91.
    View in: PubMed
  122. Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, Hirsch MS, Walker BD. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis. 2003 Dec 15; 37(12):1693-8.
    View in: PubMed
  123. Xiang SH, Wang L, Abreu M, Huang CC, Kwong PD, Rosenberg E, Robinson JE, Sodroski J. Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains. Virology. 2003 Oct 10; 315(1):124-34.
    View in: PubMed
  124. Choe H, Li W, Wright PL, Vasilieva N, Venturi M, Huang CC, Grundner C, Dorfman T, Zwick MB, Wang L, Rosenberg ES, Kwong PD, Burton DR, Robinson JE, Sodroski JG, Farzan M. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell. 2003 Jul 25; 114(2):161-70.
    View in: PubMed
  125. Altfeld M, Addo MM, Shankarappa R, Lee PK, Allen TM, Yu XG, Rathod A, Harlow J, O'Sullivan K, Johnston MN, Goulder PJ, Mullins JI, Rosenberg ES, Brander C, Korber B, Walker BD. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol. 2003 Jul; 77(13):7330-40.
    View in: PubMed
  126. Robbins GK, Addo MM, Troung H, Rathod A, Habeeb K, Davis B, Heller H, Basgoz N, Walker BD, Rosenberg ES. Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization. AIDS. 2003 May 23; 17(8):1121-6.
    View in: PubMed
  127. Tremblay CL, Hicks JL, Sutton L, Giguel F, Flynn T, Johnston M, Sax PE, Walker BD, Hirsch MS, Rosenberg ES, D'Aquila RT. Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection. AIDS. 2003 May 2; 17(7):1086-9.
    View in: PubMed
  128. Tong Q, Sankalé JL, Hadigan CM, Tan G, Rosenberg ES, Kanki PJ, Grinspoon SK, Hotamisligil GS. Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab. 2003 Apr; 88(4):1559-64.
    View in: PubMed
  129. Montefiori DC, Altfeld M, Lee PK, Bilska M, Zhou J, Johnston MN, Gao F, Walker BD, Rosenberg ES. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual. J Immunol. 2003 Apr 1; 170(7):3906-14.
    View in: PubMed
  130. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, Johnston MN, Corcoran C, Wurcel AG, Fitzpatrick CA, Feeney ME, Rodriguez WR, Basgoz N, Draenert R, Stone DR, Brander C, Goulder PJ, Rosenberg ES, Altfeld M, Walker BD. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol. 2003 Feb; 77(3):2081-92.
    View in: PubMed
  131. Kaufmann DE, Rosenberg ES. The value of preserving HIV-specific immune responses. J HIV Ther. 2003 Feb; 8(1):19-25.
    View in: PubMed
  132. Thorner A, Rosenberg E. Early versus delayed antiretroviral therapy in patients with HIV infection : a review of the current guidelines from an immunological perspective. Drugs. 2003; 63(13):1325-37.
    View in: PubMed
  133. Montefiori DC, Altfeld M, Lee PK, Bilska M, Johnston MN, Gao F, Walker BD, Rosenberg ES. Viremia control despite escape from rapid and potent neutralizing antibody response after treatment-interruption in an HIV-1 infected individual. Journal of Immunology. 2003; 170:3906-14.
  134. Rosenberg ES. Therapeutic vaccination: where are we now? AIDS Clin Care. 2003 Jan; 15(1):1-3.
    View in: PubMed
  135. Gandhi RT, Wurcel A, Rosenberg, ES, Johnston MN, Hellman N, Bates M, Hirsch MS, Walker BD. Progressive reversion of human immunodeficiency virus Type 1 resistance mutations in vivo after transmission of multiply drug-resistant virus. Clinical Infectious Diseases. 2003; 37:1693-98.
  136. Cohen GB, Islam SA, Noble MS, Lau C, Brander C, Altfeld MA, Rosenberg ES, Schmitz JE, Cameron TO, Kalams SA. Clonotype tracking of TCR repertoires during chronic virus infections. Virology. 2002 Dec 20; 304(2):474-84.
    View in: PubMed
  137. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, Montefiori DC, O'Connor DH, Davis BT, Lee PK, Maier EL, Harlow J, Goulder PJ, Brander C, Rosenberg ES, Walker BD. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature. 2002 Nov 28; 420(6914):434-9.
    View in: PubMed
  138. Cameron TO, Norris PJ, Patel A, Moulon C, Rosenberg ES, Mellins ED, Wedderburn LR, Stern LJ. Labeling antigen-specific CD4(+) T cells with class II MHC oligomers. J Immunol Methods. 2002 Oct 1; 268(1):51-69.
    View in: PubMed
  139. Addo MM, Yu XG, Rosenberg ES, Walker BD, Altfeld M. Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection. DNA Cell Biol. 2002 Sep; 21(9):671-8.
    View in: PubMed
  140. Lotti B, Wendland T, Furrer H, Yawalkar N, von Greyerz S, Schnyder K, Brandes M, Vernazza P, Wagner R, Nguyen T, Rosenberg E, Pichler WJ, Brander C. Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines. J Clin Immunol. 2002 Sep; 22(5):253-62.
    View in: PubMed
  141. Yu XG, Addo MM, Rosenberg ES, Rodriguez WR, Lee PK, Fitzpatrick CA, Johnston MN, Strick D, Goulder PJ, Walker BD, Altfeld M. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol. 2002 Sep; 76(17):8690-701.
    View in: PubMed
  142. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS. 2002 May 24; 16(8):1119-29.
    View in: PubMed
  143. Addo MM, Altfeld M, Rathod A, Yu M, Yu XG, Goulder PJ, Rosenberg ES, Walker BD. HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infection. AIDS. 2002 May 3; 16(7):1071-3.
    View in: PubMed
  144. Norris PJ, Rosenberg ES. CD4(+) T helper cells and the role they play in viral control. J Mol Med (Berl). 2002 Jul; 80(7):397-405.
    View in: PubMed
  145. Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg ES, Lucas M, Klenerman P, Chung RT, Walker BD. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol. 2002 Mar; 76(6):2817-26.
    View in: PubMed
  146. Addo MM, Rosenberg ES. Cellular immune responses in transplantation-associated chronic viral infections. Transpl Infect Dis. 2002 Mar; 4(1):31-40.
    View in: PubMed
  147. Yu XG, Shang H, Addo MM, Eldridge RL, Phillips MN, Feeney ME, Strick D, Brander C, Goulder PJ, Rosenberg ES, Walker BD, Altfeld M. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses. AIDS. 2002 Feb 15; 16(3):321-8.
    View in: PubMed
  148. Norris PJ, Rosenberg ES. CD4(+)T helper cells and the role they play in viral control. Journal of Molecular Medicine. 2002; 80(7):397-405.
  149. Rosenberg E. Backgrounder: recognizing and diagnosing primary HIV infection. Res Initiat Treat Action. 2002; 7(2):5-10.
    View in: PubMed
  150. Addo, MM, Rosenberg ES. Cellular immune responses in transplantation-associated chronic viral infections. Transplant Infectious Disease. 2002; 4(1):31-40.
  151. Goulder PJ, Pasquier C, Holmes EC, Liang B, Tang Y, Izopet J, Saune K, Rosenberg ES, Burchett SK, McIntosh K, Barnardo M, Bunce M, Walker BD, Brander C, Phillips RE. Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett. 2001 Nov 1; 79(1-2):109-16.
    View in: PubMed
  152. Montefiori DC, Hill TS, Vo HT, Walker BD, Rosenberg ES. Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection. J Virol. 2001 Nov; 75(21):10200-7.
    View in: PubMed
  153. Norris PJ, Sumaroka M, Brander C, Moffett HF, Boswell SL, Nguyen T, Sykulev Y, Walker BD, Rosenberg ES. Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones. J Virol. 2001 Oct; 75(20):9771-9.
    View in: PubMed
  154. Altfeld M, Addo MM, Eldridge RL, Yu XG, Thomas S, Khatri A, Strick D, Phillips MN, Cohen GB, Islam SA, Kalams SA, Brander C, Goulder PJ, Rosenberg ES, Walker BD. Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol. 2001 Sep 1; 167(5):2743-52.
    View in: PubMed
  155. Walensky RP, Rosenberg ES, Ferraro MJ, Losina E, Walker BD, Freedberg KA. Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody. Clin Infect Dis. 2001 Aug 15; 33(4):570-2.
    View in: PubMed
  156. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BT, Walker BD. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature. 2001 Jul 19; 412(6844):334-8.
    View in: PubMed
  157. Day CL, Shea AK, Altfeld MA, Olson DP, Buchbinder SP, Hecht FM, Rosenberg ES, Walker BD, Kalams SA. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J Virol. 2001 Jul; 75(14):6279-91.
    View in: PubMed
  158. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, Uglialoro AM, Clavijo OP, Rosenberg ES, Kalams SA, Braun JD, Boswell SL, Walker BD, Goldfeld AE. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A. 2001 Apr 24; 98(9):5140-5.
    View in: PubMed
  159. Addo MM, Altfeld M, Rosenberg ES, Eldridge RL, Philips MN, Habeeb K, Khatri A, Brander C, Robbins GK, Mazzara GP, Goulder PJ, Walker BD. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1781-6.
    View in: PubMed
  160. Norris PJ, Rosenberg ES. Cellular immune response to human immunodeficiency virus. AIDS. 2001 Feb; 15 Suppl 2:S16-21.
    View in: PubMed
  161. Altfeld MA, Livingston B, Reshamwala N, Nguyen PT, Addo MM, Shea A, Newman M, Fikes J, Sidney J, Wentworth P, Chesnut R, Eldridge RL, Rosenberg ES, Robbins GK, Brander C, Sax PE, Boswell S, Flynn T, Buchbinder S, Goulder PJ, Walker BD, Sette A, Kalams SA. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J Virol. 2001 Feb; 75(3):1301-11.
    View in: PubMed
  162. Goulder PJ, Addo MM, Altfeld MA, Rosenberg ES, Tang Y, Govender U, Mngqundaniso N, Annamalai K, Vogel TU, Hammond M, Bunce M, Coovadia HM, Walker BD. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays. J Virol. 2001 Feb; 75(3):1339-47.
    View in: PubMed
  163. Goulder PJ, Altfeld MA, Rosenberg ES, Nguyen T, Tang Y, Eldridge RL, Addo MM, He S, Mukherjee JS, Phillips MN, Bunce M, Kalams SA, Sekaly RP, Walker BD, Brander C. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med. 2001 Jan 15; 193(2):181-94.
    View in: PubMed
  164. Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001 Jan 15; 193(2):169-80.
    View in: PubMed
  165. Walensky RP, Rosenberg ES, Ferraro MJ, Losina E, Walker BD, Freedberg KA. Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody. Clinical Infectious Diseases. 2001; 33:570-572.
  166. Hurtado R, Rosenberg ES. Before seroconversion: The clinical and scientific events of acute HIV-1 infection and the immunologic benefits of treatment. AIDS Clinical Care. 2001.
  167. Addo MM, Altfeld M, Rosenberg ES, Eldridge RL, Phillips MN, Habeeb K, Khatri A, Brander C. Robbins GK, Mazzara GP, Goulder PJR, Walker BD. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T-lymphocytes (CTL) derived from HIV-1 infected individuals. Proceedings of the National Academy of Sciences USA. 2001; 98:1781-1786.
  168. Norris PJ, Sumaroka M. Brander C, Moffett HF, Boswell SL, Nguyen T, Sykulev Y, Walker BD, Rosenberg ES,. Multiple effector functions mediated by HIV-1-specific CD4+T cell clones. Journal of Virology. 2001; 75:9771-9779.
  169. Goulder PJ, Tang Y, Brander C, Betts MR, Altfeld M, Annamalai K, Trocha A, He S, Rosenberg ES, Ogg G, O'Callaghan CA, Kalams SA, McKinney RE, Mayer K, Koup RA, Pelton SI, Burchett SK, McIntosh K, Walker BD. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med. 2000 Dec 18; 192(12):1819-32.
    View in: PubMed
  170. Tremblay CL, Giguel F, Merrill DP, Wong JT, Rosenberg E, Kalams S, Walker BD, D'Aquila RT, Hirsch MS. Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture method. J Clin Microbiol. 2000 Nov; 38(11):4246-8.
    View in: PubMed
  171. Walker BD, Rosenberg ES. Containing HIV after infection. Nat Med. 2000 Oct; 6(10):1094-5.
    View in: PubMed
  172. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD. Immune control of HIV-1 after early treatment of acute infection. Nature. 2000 Sep 28; 407(6803):523-6.
    View in: PubMed
  173. Martinez-Picado J, DePasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, Rosenberg E, Gunthard HF, Sutton L, Savara A, Petropoulos CJ, Hellmann N, Walker BD, Richman DD, Siliciano R, D'Aquila RT. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A. 2000 Sep 26; 97(20):10948-53.
    View in: PubMed
  174. Altfeld MA, Trocha A, Eldridge RL, Rosenberg ES, Phillips MN, Addo MM, Sekaly RP, Kalams SA, Burchett SA, McIntosh K, Walker BD, Goulder PJ. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol. 2000 Sep; 74(18):8541-9.
    View in: PubMed
  175. Altfeld M, Rosenberg ES. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr Opin Immunol. 2000 Aug; 12(4):375-80.
    View in: PubMed
  176. Goulder PJ, Brander C, Annamalai K, Mngqundaniso N, Govender U, Tang Y, He S, Hartman KE, O'Callaghan CA, Ogg GS, Altfeld MA, Rosenberg ES, Cao H, Kalams SA, Hammond M, Bunce M, Pelton SI, Burchett SA, McIntosh K, Coovadia HM, Walker BD. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol. 2000 Jun; 74(12):5679-90.
    View in: PubMed
  177. Hay CM, Rosenberg ES. Immunology of HIV-1 infection. Up-To-Date Online. 2000.
  178. Martinez-Picardo J, DePasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, Rosenberg ES, Gunthard HF, Sutton L, Savara A, Petropoulos C, Hellmann N, Walker BD, Richman DD, D'Aquila RT. Antiretroviral resistance during successful therapy of human immunodeficiency virus type 1 infection. Proceedings of the National Adacemy of Sciences USA. 2000; 97:10948-53.
  179. Rosenberg, ES, Rubin RH. Infections in renal transplant recipients. Management of Infections in Immunocompromised Patients. 2000; 267-294.
  180. Cosimi L, Rosenberg ES. The characterization of HIV-1 specific CD4+T helper epitopes. HIV Molecular Immunology Database. 2000.
  181. Rubin RH, Rosenberg ES. Infection in solid organ transplantation: An introduction. Management of infections in immunocompromised patients. 2000; 247-266.
  182. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Walkes B, Eldridge RL, Robbins GK, D'Aquila RD, Goulder PJR, Walker BD. Immune control of HIV-1 following early treatment of acute infection. Nature. 2000; 407:523-526.
  183. Altfeld M, Rosenberg ES. The role of CD4(+) T helper cells in the cytotoxic T lumphocyte response to HIV-1. Current Opinions in Immunology. 2000; 12:375-80.
  184. Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis. 1999 Dec; 180(6):1827-32.
    View in: PubMed
  185. Lori F, Rosenberg E, Lieberman J, Foli A, Maserati R, Seminari E, Alberici F, Walker B, Lisziewicz J. Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters. AIDS Res Hum Retroviruses. 1999 Oct 10; 15(15):1333-8.
    View in: PubMed
  186. Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD, Richman DD. Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA. 1999 Sep 22-29; 282(12):1142-9.
    View in: PubMed
  187. Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, Shea AK, Trocha AK, Walker BD. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol. 1999 Aug; 73(8):6715-20.
    View in: PubMed
  188. Lisziewicz J, Rosenberg E, Lieberman J, Jessen H, Lopalco L, Siliciano R, Walker B, Lori F. Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med. 1999 May 27; 340(21):1683-4.
    View in: PubMed
  189. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999 May; 5(5):512-7.
    View in: PubMed
  190. Rosenberg ES, Caliendo AM, Walker BD. Acute HIV infection among patients tested for mononucleosis. N Engl J Med. 1999 Mar 25; 340(12):969.
    View in: PubMed
  191. Rosenberg ES, LaRosa L, Flynn T, Robbins G, Walker BD. Characterization of HIV-1-specific T-helper cells in acute and chronic infection. Immunol Lett. 1999 Mar; 66(1-3):89-93.
    View in: PubMed
  192. Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before serovoncersion is associated with normalized immune parameters and limited viral reservoir. Journal of Infectious Diseases. 1999; 180:1827-32.
  193. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B,Gange S, Gallant J, Siliciano RF. Latent infection of CD4+T cells provides a mechanism for lifelong persustence of HIV-1, even in patients on effective combination therapy. Nature. 1999; 5:512-7.
  194. Rosenberg ES, Walker BD. HIV type 1-specific helper T cells: a critical host defense. AIDS Res Hum Retroviruses. 1998 Jun; 14 Suppl 2:S143-7.
    View in: PubMed
  195. Walker BD, Rosenberg ES, Hay CM, Basgoz N, Yang OO. Immune control of HIV-1 replication. Adv Exp Med Biol. 1998; 452:159-67.
    View in: PubMed
  196. Hay C, Rosenberg E. Immunologic response to HIV. AIDS Clin Care. 1998 Jan; 10(1):1-3.
    View in: PubMed
  197. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997 Nov 21; 278(5342):1447-50.
    View in: PubMed
  198. Rosenberg E, Cotton D. Primary HIV infection and the acute retroviral syndrome. AIDS Clin Care. 1997 Mar; 9(3):19, 23-5.
    View in: PubMed
  199. Modan B, Shpilberg O, Baruch Y, Sikuler E, Anis E, Ashur Y, Chetrit A, Luxenburg O, Rosenberg E, Rosenthol N, et al. The need for liver transplantation: a nationwide estimate based on consensus review. Lancet. 1995 Sep 9; 346(8976):660-2.
    View in: PubMed
  200. Schneiderman LJ, Teetzel H, Kronick R, Anderson JP, Langer RD, Rosenberg E, Kaplan RM. Advance directives, apples and oranges. Arch Intern Med. 1995 Jan 23; 155(2):217-8.
    View in: PubMed
  201. Rosenberg ES, Cutler SA. The effect of cigarette smoking on the long-term success of guided tissue regeneration: a preliminary study. Ann R Australas Coll Dent Surg. 1994 Apr; 12:89-93.
    View in: PubMed
  202. Evian CI, Cutler SA, Rosenberg ES, Shah RK. Altered passive eruption: the undiagnosed entity. J Am Dent Assoc. 1993 Oct; 124(10):107-10.
    View in: PubMed
  203. Rosenberg ES, Torosian JP, Hammond BF, Cutler SA. Routine anaerobic bacterial culture and systemic antibiotic usage in the treatment of adult periodontitis: a 6-year longitudinal study. Int J Periodontics Restorative Dent. 1993; 13(3):213-43.
    View in: PubMed
  204. Rosenberg ES, Cutler SA. Periodontal considerations for esthetics: edentulous ridge augmentation. Curr Opin Cosmet Dent. 1993; 61-6.
    View in: PubMed
  205. Rosenberg ES, Cutler SA. Guided tissue regeneration and GTAM for periodontal regenerative therapy, ridge augmentation and dental implantology. Alpha Omegan. 1992; 85(4):25-8.
    View in: PubMed
  206. Rosenberg E, Brown H, Jackson D, Cooper K. Basic medical physiology: the whole is more than the sum of its parts. Am J Physiol. 1991 Dec; 261(6 Pt 3):S30-3.
    View in: PubMed
  207. Sandin RL, Rodriguez ER, Rosenberg E, Porter-Jordan K, Caparas M, Nasim S, Rockis M, Keiser JF, Garrett CT. Comparison of sensitivity for human cytomegalovirus of the polymerase chain reaction, traditional tube culture and shell vial assay by sequential dilutions of infected cell lines. J Virol Methods. 1991 May; 32(2-3):181-91.
    View in: PubMed
  208. Filer D, White D, Kindler SH, Rosenberg E. Myxospore coat synthesis in Myxococcus xanthus: in vivo incorporation of acetate and glycine. J Bacteriol. 1977 Sep; 131(3):751-8.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_